Kaname Nakatani

Kaname Nakatani

Auto-generated profile, based on publicly available information

Kaname Nakatani

Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KNKaname Nakatani
Kaname Nakatani
DTDevon A. Thompson
Devon A. Thompson
ABAndreas Barthel
Andreas Barthel
HSHiroshi Sakaue
Hiroshi Sakaue
WLWei Liu
Wei Liu
RRRichard A. Roth
Richard A. Roth
We measured the insulin-stimulated amount of Akt1, Akt2, and Akt3 enzymatic activities in four breast cancer cell lines and three prostate cancer cell lines. In the estrogen receptor-deficient breast cancer cells and the androgen-insensitive prostate cells, the amount of Akt3 enzymatic activity was approximately 20–60-fold higher than in the cells that were estrogen- or androgen-responsive. In contrast, the levels of Akt1 and -2 were not increased in these cells. The increase in Akt3 enzyme activity correlated with an increase in both Akt3 mRNA and protein. In a prostate cancer cell line lacking the tumor suppressor PTEN (a lipid and protein phosphatase), the basal enzymatic activity of Akt3 was constitutively elevated and represented the major active Akt in these cells. Finally, reverse transcription-PCR was used to examine the Akt3 expression in 27 primary breast carcinomas. The expression levels of Akt3 were significantly higher in the estrogen receptor-negative tumors in comparison to the estrogen receptor-positive tumors. To see if the increase in Akt3 could be due to chromosomal abnormalities, the Akt3 gene was assigned to human chromosome 1q44 by fluorescence in situ hybridization and radiation hybrid cell panel analyses. These results indicate that Akt3 may contribute to the more aggressive clinical phenotype of the estrogen receptor-negative breast cancers and androgen-insensitive prostate carcinomas.

1 October 2003 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
HUHideki Urakawa
Hideki Urakawa
AKAkira Katsuki
Akira Katsuki
YSYasuhiro Sumida
Yasuhiro Sumida
Esteban C. GabazzaEsteban C. Gabazza
Esteban C. Gabazza
SMShuichi Murashima
Shuichi Murashima
YAYukihiko Adachi
Yukihiko Adachi
To investigate the direct relationship of oxidative stress with obesity and insulin resistance in men, we measured the plasma levels of 8-epi-prostaglandin F2α (PGF2α) in 14 obese and 17 nonobese men and evaluated their relationship with body mass index; body fat weight; visceral, sc, and total fat areas, measured by computed tomography; and glucose infusion rate during a euglycemic hyperinsulinemic clamp study. Obese men had significantly higher plasma concentrations of 8-epi-PGF2α than nonobese men (P < 0.05). The plasma levels of 8-epi-PGF2α were significantly correlated with body mass index (r = 0.408; P < 0.05), body fat weight (r = 0.467; P < 0.05), visceral (r = 0.387; P < 0.05) and total fat area (r = 0.359; P < 0.05) in all (obese and nonobese) men. There was also a significant correlation between the plasma levels of 8-epi-PGF2α and glucose infusion rate in obese men (r = −0.552; P < 0.05) and all men (r = −0.668; P < 0.01). In all subjects, the plasma levels of 8-epi-PGF2α were significantly correlated with fasting serum levels of insulin (r = 0.487; P < 0.01). In brief, these findings showed that the circulating levels of 8-epi-PGF2α are related to adiposity and insulin resistance in men. Although correlation does not prove causation, the results of this study suggest that obesity is an important factor for enhanced oxidative stress and that this oxidative stress triggers the development of insulin resistance in men.

1 July 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ABAndreas Barthel
Andreas Barthel
SOSteven T. Okino
Steven T. Okino
JLJinfang Liao
Jinfang Liao
KNKaname Nakatani
Kaname Nakatani
JLJinping Li
Jinping Li
RRRichard A. Roth
Richard A. Roth
We used mouse hepatoma (Hepa1c1c7) cells to study the role of the serine/threonine kinase Akt in the induction ofGLUT1 gene expression. In order to selectively turn on the Akt kinase cascade, we expressed a hydroxytamoxifen-regulatable form of Akt (myristoylated Akt1 estrogen receptor chimera (MER-Akt1)) in the Hepa1c1c7 cells; we verified that hydroxytamoxifen stimulates MER-Akt1 activity to a similar extent as the activation of endogenous Akt by insulin. Our studies reveal that stimulation of MER-Akt1 by hydroxytamoxifen induces GLUT1 mRNA and protein accumulation to levels comparable to that induced by insulin; therefore, activation of the Akt cascade suffices to induce GLUT1 gene expression in this cell system. Furthermore, expression of a kinase-inactive Akt mutant partially inhibits the response of the GLUT1 gene to insulin. Additional studies reveal that the induction of GLUT1 mRNA by Akt and by insulin reflects increased mRNA synthesis and not decreased mRNA degradation. Our findings imply that theGLUT1 gene responds to insulin at the transcriptional level and that Akt mediates a step in the activation of GLUT1gene expression in this system.

1 August 2003 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
AKAkira Katsuki
Akira Katsuki
YSYasuhiro Sumida
Yasuhiro Sumida
HUHideki Urakawa
Hideki Urakawa
Esteban C. GabazzaEsteban C. Gabazza
Esteban C. Gabazza
SMShuichi Murashima
Shuichi Murashima
YAYukihiko Adachi
Yukihiko Adachi
OBJECTIVE—The purpose of this study was to investigate the association between visceral adiposity or triglyceride (TG) metabolism and insulin resistance in metabolically obese, normal weight (MONW) Japanese individuals with normal glucose tolerance. RESEARCH DESIGN AND METHODS—We evaluated body fat areas, lipid profiles, and the glucose infusion rate (GIR) during a euglycemic-hyperinsulinemic clamp study in 20 MONW subjects (BMI <25 kg/m2and visceral fat areas 100 cm2) with normal glucose tolerance. Body fat areas were measured by computed tomography scans. Control data were obtained from 20 normal subjects (BMI <25 kg/m2 and visceral fat areas <100 cm2). RESULTS—MONW subjects showed a significant increase in fasting serum levels of TG (P < 0.01) and a decrease in GIR (P < 0.01) compared with normal subjects. There were significant correlations between visceral fat areas (r = −0.563, P < 0.01) or serum levels of TG (r = −0.474, P < 0.05) and GIR in MONW subjects. Multiple regression analyses showed that visceral fat areas (F = 7.702, P < 0.02) and serum levels of TG (F = 7.114, P < 0.05) were significantly associated with GIR in all (MONW and normal) subjects. CONCLUSIONS—Increased visceral fat and serum levels of TG are associated with insulin resistance in Japanese MONW subjects with normal glucose tolerance. Excess visceral fat and elevated TG levels may play important roles in the development of insulin resistance in Japanese MONW subjects with normal glucose tolerance.

1 January 2006 in Thrombosis Research
Verified
Journal Article
Closed access
YAYasunori Abe
Yasunori Abe
HWHideo Wada
Hideo Wada
HTHiroaki Tomatsu
Hiroaki Tomatsu
ASAkane Sakaguchi
Akane Sakaguchi
JNJunji Nishioka
Junji Nishioka
TNTsutomu Nobori
Tsutomu Nobori

1 April 1999 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
KNKaname Nakatani
Kaname Nakatani
HSHiroshi Sakaue
Hiroshi Sakaue
DTDevon A. Thompson
Devon A. Thompson
RWRonald J. Weigel
Ronald J. Weigel
RRRichard A. Roth
Richard A. Roth
The family of protein kinases called Akt, protein kinase B (PKB), or related to A and C kinase (RAC) have been implicated in numerous biological processes including adipocyte and muscle differentiation, glycogen synthesis, glucose uptake, apoptosis and cellular proliferation. There are 3 known isoforms of this enzyme in mammalian cells (1/alpha, 2/beta and 3/gamma). Akt1 and 2 contain a key regulatory serine phosphorylation site in the carboxy-terminal region of the protein. However, the reported sequence of the rat Akt3 protein differed significantly from this in that it lacked 25 amino acids in the C-terminal region, including this key regulatory serine phosphorylation site (Biochem. Biophys. Res. Commun. 216, 526-534). In the present studies we show that the deduced sequence of human Akt3 contains this serine and that it is phosphorylated in response to insulin. These results indicate that human Akt3 is regulated similarly to Akt1 and Akt2.